May 17, 2026European Urology0 citations

Letter to the Editor: Advanced and Metastatic Prostate Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment, and Follow-up

BLBram De Laere AMAshkan Mortezavi MEMartin Eklund

Key Points

Key points are not available for this paper at this time.

Abstract

No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Laere et al. (Fri,) studied this question.

synapsesocial.com/papers/6a095d657880e6d24efe2a25 https://doi.org/https://doi.org/10.1016/j.eururo.2026.04.028

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up2026 · 18 citations
2Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial2024 · 29 citations
3Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer2015 · 2,883 citations
4Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer2019 · 680 citations
5Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer2019 · 1,551 citations

Demander à l'IA

Bookmark

View Full Paper